▁There 5.83203125
▁is 1.626953125
▁currently 4.72265625
▁a 1.4619140625
▁severe 5.44140625
▁lack 2.92578125
▁of 0.0206146240234375
▁information 3.65625
▁about 1.4462890625
▁the 0.7919921875
▁effects 3.875
▁of 0.1082763671875
▁op 6.61328125
i 3.775390625
ates 0.028350830078125
. 3.91015625
▁They 5.02734375
▁manage 9.1875
▁pain 2.126953125
▁successfully 6.66796875
, 1.00390625
▁but 0.283447265625
▁the 2.6328125
▁past 8.8984375
▁few 1.150390625
▁dec 1.5859375
ades 3.6597251892089844e-05
▁indicated 9.8828125
▁the 2.80859375
▁growing 3.595703125
▁concern 3.19140625
▁regarding 3.37109375
▁op 1.9833984375
iate 0.40185546875
▁ab 1.3798828125
use 0.0094146728515625
▁in 3.419921875
▁forms 9.8515625
▁of 0.2381591796875
▁over 3.35546875
d 0.0738525390625
ose 0.31982421875
▁and 0.79541015625
▁add 0.52490234375
iction 0.01433563232421875
. 0.09808349609375
▁A 4.12890625
▁more 5.3828125
▁manage 9.1015625
able 0.00284576416015625
▁and 2.099609375
▁sa 2.26171875
fer 0.0001596212387084961
▁alternative 1.9326171875
▁might 4.98046875
▁be 0.2481689453125
▁medical 5.8203125
▁mar 0.386474609375
iju 0.0010805130004882812
ana 4.756450653076172e-05
. 0.61962890625
▁However 4.3359375
, 0.0156707763671875
▁the 1.8798828125
▁legal 3.5546875
▁status 1.0693359375
▁and 3.41015625
▁novel 10.4609375
ty 0.212646484375
▁of 0.1463623046875
▁this 1.8681640625
▁drug 1.962890625
▁do 4.91796875
▁not 0.0391845703125
▁allow 0.98291015625
▁finding 7.9765625
▁a 2.63671875
▁large 3.37890625
▁number 0.97216796875
▁of 0.004169464111328125
▁studies 0.923828125
▁on 1.787109375
▁its 1.1279296875
▁effect 2.193359375
iveness 0.181640625
. 0.6806640625
▁Specifically 8.984375
, 0.08868408203125
▁it 2.787109375
▁concerns 5.34375
▁the 0.99365234375
▁emot 9.828125
ional 0.0372314453125
▁condition 5.36328125
▁of 0.623046875
▁patients 1.1826171875
▁experien 6.1328125
cing 9.5367431640625e-05
▁chron 1.0595703125
ic 0.0005893707275390625
▁pain 0.08697509765625
. 0.386474609375
▁This 3.044921875
▁research 2.75390625
▁paper 2.28125
▁a 1.650390625
ims 0.0002751350402832031
▁to 0.128662109375
▁analyze 2.8046875
▁levels 10.6796875
▁of 0.037017822265625
▁de 1.8427734375
pression 0.055816650390625
▁and 0.67919921875
▁anx 0.1328125
iety 0.0002694129943847656
▁among 1.494140625
▁people 2.515625
▁receiving 4.2109375
▁ther 4.98046875
apy 0.0355224609375
▁by 4.61328125
▁comparing 10.3046875
▁the 1.875
▁effects 2.451171875
▁of 0.0289154052734375
▁ph 5.6328125
arma 0.354736328125
ce 0.01131439208984375
ut 0.0002663135528564453
ical 0.0173492431640625
▁op 1.4140625
io 2.65625
ids 0.09234619140625
▁and 0.501953125
▁MM 4.1953125
. 2.421875
<0x0A> 0.3994140625
The 1.326171875
▁study 2.083984375
▁was 1.53125
▁conducted 0.56396484375
▁in 1.359375
▁the 1.6083984375
▁form 2.8125
▁of 0.00238800048828125
▁collection 11.1640625
▁and 0.78369140625
▁analysis 0.343505859375
▁of 0.00823974609375
▁statistical 4.06640625
▁data 0.0965576171875
. 1.0078125
▁Part 4.97265625
icip 0.2059326171875
ants 0.055999755859375
▁were 0.57470703125
▁rec 4.03125
ru 0.0014181137084960938
ited 0.00010228157043457031
▁for 4.2109375
▁six 6.37109375
▁months 0.59814453125
▁at 3.728515625
▁two 2.568359375
▁major 4.5625
▁pain 2.79296875
▁relief 5.21875
▁cent 0.81591796875
ers 0.055084228515625
▁in 0.5693359375
▁Israel 5.71875
. 0.342529296875
▁The 1.451171875
▁research 2.64453125
ers 0.93212890625
▁used 2.23828125
▁The 6.765625
▁De 3.103515625
pression 0.022918701171875
▁Module 7.2578125
▁of 0.7138671875
▁the 0.220458984375
▁Pat 3.013671875
ient 0.00774383544921875
▁Health 0.02947998046875
▁Question 0.015655517578125
naire 0.025726318359375
▁and 2.4296875
▁the 0.75341796875
▁General 1.203125
ized 0.689453125
▁An 0.004009246826171875
x 6.473064422607422e-05
iety 0.0004343986511230469
▁Dis 0.11712646484375
order 0.0211639404296875
▁Sc 1.451171875
ale 0.0027828216552734375
▁to 0.79638671875
▁interview 7.88671875
▁participants 2.85546875
, 4.09375
▁evaluate 4.83984375
▁their 0.51416015625
▁answers 4.15234375
, 0.3916015625
▁and 0.0350341796875
▁conduct 5.26953125
▁the 1.8232421875
▁study 2.705078125
. 0.09173583984375
▁To 4.87890625
▁specifically 9.9453125
▁evaluate 3.064453125
▁and 5.34765625
▁compare 0.464111328125
▁the 0.4345703125
▁prob 10.8125
abilities 0.11700439453125
▁of 0.08294677734375
▁de 0.84326171875
pression 0.062225341796875
▁or 3.9296875
▁anx 0.046966552734375
iety 0.0005702972412109375
▁among 1.5263671875
▁the 1.9287109375
▁diverse 9.546875
▁groups 0.744140625
, 0.72216796875
▁the 0.4814453125
▁study 3.009765625
▁used 1.23046875
▁multiple 5.30859375
▁log 0.48388671875
istic 0.025115966796875
▁regression 0.27734375
▁analysis 1.3037109375
▁and 2.87890625
▁chose 8.78125
▁medical 6.5234375
▁mar 0.08721923828125
iju 0.0010118484497070312
ana 2.0623207092285156e-05
▁as 0.61474609375
▁the 0.84765625
▁control 3.306640625
▁group 0.81103515625
. 0.259521484375
<0x0A> 0.4052734375
Chr 6.8671875
onic 0.0174713134765625
▁pain 0.127685546875
▁is 1.4521484375
▁still 5.734375
▁considered 3.1875
▁to 1.9541015625
▁be 0.0750732421875
▁an 2.939453125
▁extreme 6.1171875
▁issue 3.505859375
▁among 2.96875
▁at 9.3125
▁least 0.14013671875
▁ 0.349609375
8 3.6953125
% 1.689453125
▁of 0.041168212890625
▁the 0.53857421875
▁residents 7.28515625
▁of 0.36962890625
▁progress 12.28125
ive 0.10223388671875
▁countries 0.5078125
. 0.490478515625
▁The 1.9638671875
▁introduction 6.80859375
▁of 0.0273895263671875
▁the 3.376953125
▁study 4.5390625
▁describes 5.7578125
▁the 0.5771484375
▁apparent 8.453125
▁link 3.8984375
▁between 0.07568359375
▁pain 2.119140625
▁and 0.48779296875
▁dem 9.2109375
oral 1.8916015625
ization 0.07025146484375
. 1.1982421875
▁Chron 4.60546875
ic 0.00666046142578125
▁pain 0.1588134765625
▁is 1.49609375
▁always 5.640625
▁accompanied 1.52734375
▁by 0.051788330078125
▁negative 4.2421875
▁emot 0.49853515625
ional 1.1796875
▁experiences 3.083984375
▁and 2.228515625
▁blocks 11.375
▁a 2.880859375
▁person 0.70654296875
’ 0.5859375
s 0.0014495849609375
▁ability 1.076171875
▁to 0.0186767578125
▁receive 6.37890625
▁joy 3.546875
▁and 1.4599609375
▁satisfaction 2.40234375
▁from 0.7080078125
▁life 0.76416015625
. 0.2021484375
▁The 1.8037109375
▁research 2.19140625
▁investig 7.24609375
ates 0.41162109375
▁the 0.498779296875
▁development 6.8671875
▁of 0.07379150390625
▁de 0.80322265625
pression 0.09942626953125
▁and 0.328857421875
▁anx 0.049774169921875
iety 0.0005807876586914062
▁among 1.0869140625
▁patients 1.109375
▁receiving 2.0390625
▁ph 3.130859375
arma 0.05926513671875
ce 0.0017557144165039062
ut 7.033348083496094e-06
ical 0.004405975341796875
▁op 0.57861328125
io 0.305419921875
ids 0.131103515625
▁and 0.75244140625
▁medical 0.8564453125
▁mar 0.0791015625
iju 0.0004634857177734375
ana 1.52587890625e-05
▁( 3.58203125
MM 0.8681640625
) 1.2685546875
▁as 1.396484375
▁severe 10.0625
▁pain 0.50830078125
kill 2.8359375
ers 0.0002474784851074219
. 0.16064453125
▁It 3.23046875
▁comp 4.26953125
ares 0.0059051513671875
▁the 0.49365234375
▁effic 4.79296875
acy 0.005527496337890625
▁of 0.22607421875
▁pres 6.92578125
cri 2.318359375
ptions 1.13671875
▁and 1.2705078125
▁exam 4.55859375
ines 0.004726409912109375
▁the 0.5654296875
▁possibility 3.26171875
▁of 0.09503173828125
▁post 8.734375
- 0.52587890625
tre 1.5908203125
at 0.00176239013671875
ment 0.003452301025390625
▁de 1.1171875
pression 0.03765869140625
. 1.77734375
<0x0A> 0.445556640625
The 0.58447265625
▁analysis 4.125
▁of 0.8408203125
▁any 9.2890625
▁human 6.69921875
▁reaction 4.703125
▁has 5.0546875
▁a 2.001953125
▁high 3.412109375
▁potential 3.185546875
▁of 1.87109375
▁subject 3.099609375
iveness 3.623046875
▁and 1.5732421875
▁bias 1.6337890625
, 2.09375
▁especially 1.8720703125
▁regarding 3.599609375
▁people 5.1796875
▁in 3.5703125
▁severe 2.740234375
▁pain 0.51708984375
▁and 2.5078125
▁un 5.921875
stable 1.19140625
▁emot 0.91748046875
ional 0.087890625
▁condition 1.876953125
. 0.06744384765625
▁Perhaps 8.4453125
▁some 6.140625
▁patients 1.921875
▁tend 4.86328125
▁to 0.00841522216796875
▁ex 2.31640625
agger 0.01224517822265625
ate 0.0015153884887695312
▁their 0.8974609375
▁de 3.078125
press 1.9306640625
ive 0.06304931640625
▁state 2.408203125
▁or 1.9345703125
▁vice 5.96875
▁vers 0.03350830078125
a 6.389617919921875e-05
, 0.966796875
▁de 7.0234375
- 2.673828125
emph 0.458984375
as 0.002544403076171875
ize 0.051361083984375
▁serious 6.87109375
▁difficulties 5.875
. 0.7421875
▁Because 5.98046875
▁the 2.73046875
▁survey 5.3671875
▁responses 7.171875
▁were 1.462890625
▁thoroughly 8.9765625
▁anonymous 2.521484375
, 0.2239990234375
▁the 0.7177734375
▁research 0.75927734375
ers 0.220947265625
▁were 2.564453125
▁unable 2.58203125
▁to 0.0014352798461914062
▁carefully 7.765625
▁analyze 2.498046875
▁each 2.607421875
▁patient 2.013671875
’ 0.53173828125
s 0.0014476776123046875
▁reaction 3.798828125
▁and 1.4345703125
▁compare 3.6796875
▁it 0.92529296875
▁to 0.5400390625
▁the 0.876953125
▁actual 4.09765625
▁states 8.265625
▁of 0.552734375
▁condition 6.99609375
. 0.3115234375
▁More 6.15625
▁accurate 3.193359375
▁answers 4.51953125
▁could 1.857421875
▁be 0.71630859375
▁obtained 1.021484375
▁by 1.3544921875
▁professional 6.03515625
▁psych 1.078125
olog 0.393798828125
ists 0.0013380050659179688
▁via 7.375
▁personal 2.76953125
▁communication 4.3515625
▁and 2.0234375
▁behavior 6.203125
al 0.295166015625
▁analysis 1.830078125
. 0.294189453125
▁However 2.4609375
, 0.00035452842712402344
▁this 1.6943359375
▁method 2.41015625
▁of 2.583984375
▁research 1.7607421875
▁is 1.189453125
▁way 6.31640625
▁more 1.1513671875
▁resource 4.83203125
- 0.268798828125
int 1.4326171875
ensive 0.023651123046875
▁and 0.443359375
▁energy 11.328125
- 0.0859375
consum 0.391357421875
ing 0.0019817352294921875
. 0.80908203125
<0x0A> 0.54736328125
The 0.8095703125
▁study 1.2958984375
▁conducted 4.4609375
▁a 2.166015625
▁correlation 6.7109375
▁type 9.8125
▁of 0.50537109375
▁research 0.91748046875
▁with 3.513671875
▁variable 8.7578125
▁measures 5.46484375
. 0.92041015625
▁It 1.6396484375
▁evaluated 4.5859375
▁the 0.646484375
▁inter 6.33984375
dep 2.392578125
end 0.00020551681518554688
ence 0.00829315185546875
▁of 0.59423828125
▁various 3.712890625
▁factors 0.8759765625
▁that 3.029296875
▁affected 3.99609375
▁the 0.42822265625
▁physical 6.75
▁and 0.2978515625
▁emot 0.57568359375
ional 0.00016927719116210938
▁condition 1.40625
▁of 0.04754638671875
▁patients 0.8779296875
▁experien 3.005859375
cing 3.838539123535156e-05
▁chron 0.34765625
ic 0.00022411346435546875
▁pain 0.0232696533203125
. 0.1378173828125
▁For 4.29296875
▁example 0.98291015625
, 0.00130462646484375
▁the 0.9453125
▁survey 5.1328125
▁showed 3.6875
▁that 0.5185546875
▁the 1.822265625
▁ratio 6.73046875
▁of 0.11083984375
▁female 3.447265625
▁patients 0.96484375
▁was 1.3740234375
▁remark 7.65234375
ably 0.0001933574676513672
▁higher 0.1915283203125
▁in 2.783203125
▁the 0.65087890625
▁op 3.888671875
i 2.125
ates 0.01105499267578125
▁group 0.1265869140625
▁compared 2.421875
▁to 0.032745361328125
▁the 0.6494140625
▁MM 0.1934814453125
▁group 0.54736328125
. 0.2264404296875
▁In 3.658203125
▁turn 3.65234375
, 0.0009722709655761719
▁people 4.8671875
▁on 4.265625
▁op 2.24609375
i 0.3623046875
ates 0.00284576416015625
▁were 1.017578125
▁more 1.0947265625
▁likely 0.267578125
▁to 0.0173187255859375
▁report 2.51953125
▁major 6.21484375
▁de 0.42529296875
press 0.845703125
ive 0.0035533905029296875
▁dis 1.1162109375
orders 1.52734375
. 1.40625
<0x0A> 2.54296875
This 3.619140625
▁type 4.6953125
▁of 0.0013608932495117188
▁study 1.9228515625
▁is 1.384765625
▁the 3.888671875
▁most 0.7568359375
▁reve 7.73828125
aling 0.0004343986511230469
▁and 1.287109375
▁inclus 7.203125
ive 0.0007562637329101562
, 2.60546875
▁as 1.6826171875
▁it 0.2161865234375
▁contains 4.7421875
▁direct 6.078125
▁responses 4.05078125
▁from 0.58447265625
▁a 3.294921875
▁large 0.83154296875
▁number 0.493896484375
▁of 0.0018072128295898438
▁participants 1.08203125
. 0.4501953125
▁All 5.55859375
▁tools 9.3203125
▁in 5.359375
▁the 0.79541015625
▁form 3.62890625
▁of 0.0208740234375
▁question 0.80859375
na 0.01360321044921875
ires 3.123283386230469e-05
▁and 0.8916015625
▁scales 2.3671875
▁have 3.263671875
▁already 4.12890625
▁been 0.39453125
▁used 2.982421875
▁and 1.361328125
▁proved 2.462890625
▁their 1.361328125
▁effic 2.9140625
acy 0.003627777099609375
▁for 3.5859375
▁collect 4.01171875
ing 0.004245758056640625
▁analyt 6.890625
ical 0.10205078125
▁data 0.167724609375
. 0.298583984375
▁It 3.33984375
▁helps 4.50390625
▁to 0.81201171875
▁system 6.328125
at 0.51953125
ize 0.0011262893676757812
▁and 1.2880859375
▁class 4.56640625
ify 0.001220703125
▁distinct 8.0625
▁kinds 6.55078125
▁of 0.01849365234375
▁information 2.07421875
▁for 4.0390625
▁subsequent 4.89453125
▁un 8.6484375
comp 4.4921875
licated 0.019439697265625
▁services 12.7265625
. 0.6640625
▁Thus 4.76953125
, 0.004482269287109375
▁research 3.779296875
ers 0.2430419921875
▁can 1.5048828125
▁compare 2.697265625
▁the 1.1513671875
▁effects 3.046875
▁of 0.07684326171875
▁medic 3.828125
ations 0.61181640625
▁on 1.56640625
▁patients 2.037109375
▁of 3.853515625
▁diverse 2.826171875
▁age 2.017578125
▁groups 3.03515625
, 0.328857421875
▁background 3.810546875
s 0.14453125
, 0.012603759765625
▁physical 4.74609375
▁conditions 1.4169921875
, 0.035675048828125
▁emot 5.4453125
ional 0.0195465087890625
▁states 1.080078125
, 0.047088623046875
▁and 0.5166015625
▁so 2.375
▁on 0.184326171875
. 0.0443115234375
<0x0A> 0.71875
Part 6.09375
icip 0.1861572265625
ants 0.11767578125
▁were 1.1669921875
▁rec 1.1806640625
ru 0.00035643577575683594
ited 0.00025725364685058594
▁for 1.5615234375
▁six 0.250732421875
▁months 0.005096435546875
▁at 0.26806640625
▁two 0.07440185546875
▁major 0.081298828125
▁pain 0.035003662109375
▁relief 0.0302581787109375
▁cent 0.0120697021484375
ers 0.0006232261657714844
▁in 0.040557861328125
▁Israel 0.01042938232421875
. 0.149658203125
▁All 4.1640625
▁patients 1.375
▁experienced 3.603515625
▁chron 0.603515625
ic 0.00010967254638671875
▁pain 0.133544921875
▁for 2.10546875
▁at 0.6171875
▁least 0.00203704833984375
▁ 1.701171875
3 1.3798828125
▁months 0.162109375
. 1.3017578125
▁The 1.3857421875
▁study 1.716796875
▁included 1.9677734375
▁ 0.5537109375
8 2.994140625
9 2.44140625
0 2.943359375
▁participants 1.6591796875
, 1.4267578125
▁of 2.65234375
▁which 0.3828125
▁ 0.09588623046875
4 1.251953125
7 2.5078125
4 2.5859375
▁( 3.177734375
5 0.09954833984375
9 4.984375
%) 0.71728515625
▁were 0.78515625
▁treated 3.568359375
▁sole 7.3125
ly 0.0002129077911376953
▁with 0.289794921875
▁op 0.91552734375
io 0.87158203125
ids 0.114990234375
, 0.5810546875
▁ 1.0556640625
3 1.189453125
2 2.263671875
9 2.435546875
▁( 0.0479736328125
4 2.513671875
1 1.0947265625
%) 0.049957275390625
▁were 1.48046875
▁treated 0.537109375
▁with 0.416748046875
▁MM 0.83251953125
, 0.316650390625
▁and 0.10247802734375
▁ 0.2239990234375
7 1.931640625
7 2.609375
▁( 0.1148681640625
8 1.921875
. 0.890625
6 2.423828125
%) 0.0604248046875
▁acquired 10.59375
▁both 0.603515625
▁( 4.953125
Fe 9.8671875
ing 1.1669921875
old 0.35498046875
▁et 0.9658203125
▁al 0.019134521484375
., 0.1883544921875
▁ 0.015289306640625
2 0.0074310302734375
0 0.0003001689910888672
1 0.1807861328125
7 1.61328125
). 0.054779052734375
▁The 1.3095703125
▁remaining 7.5625
▁ten 6.77734375
▁participants 1.2431640625
▁who 4.9921875
▁did 2.32421875
▁not 0.0059051513671875
▁receive 2.19921875
▁ph 4.25
arma 0.0989990234375
ce 0.0008554458618164062
ut 1.3113021850585938e-06
ical 0.0019330978393554688
▁op 2.033203125
io 0.1776123046875
ids 0.0228424072265625
▁and 2.734375
▁medical 1.9990234375
▁mar 0.03509521484375
iju 0.00028634071350097656
ana 5.447864532470703e-05
▁were 0.476318359375
▁with 6.8515625
dra 0.052581787109375
wn 7.545948028564453e-05
▁from 0.2252197265625
▁the 0.192626953125
▁analysis 2.18359375
▁in 5.17578125
▁the 0.990234375
▁research 4.48046875
. 0.919921875
▁Therefore 5.05859375
, 0.007442474365234375
▁it 3.900390625
▁is 1.466796875
▁not 3.013671875
▁possible 0.8056640625
▁to 0.005275726318359375
▁compreh 6.07421875
ens 0.157958984375
ively 0.0182952880859375
▁compare 1.4677734375
▁patients 4.8984375
▁taking 3.861328125
▁medic 4.08984375
ations 0.4365234375
▁with 1.373046875
▁those 1.0244140625
▁who 0.7666015625
▁do 1.640625
▁not 0.003910064697265625
. 0.57763671875
<0x0A> 0.52294921875
One 5.33203125
▁of 0.29541015625
▁the 0.00440216064453125
▁major 2.43359375
▁limitations 2.53515625
▁is 2.345703125
▁the 0.390625
▁ins 4.8515625
u 0.06134033203125
fficient 0.0792236328125
ly 3.587890625
▁high 2.798828125
▁response 3.259765625
▁rate 0.09356689453125
, 2.560546875
▁ 4.078125
5 1.783203125
7 2.58984375
% 1.6689453125
▁instead 6.15234375
▁of 0.0018949508666992188
▁ 0.63818359375
7 1.2890625
0 0.5400390625
% 1.328125
▁( 1.859375
Fe 0.63720703125
ing 0.0013275146484375
old 0.0003972053527832031
▁et 0.0239410400390625
▁al 0.0008378028869628906
., 0.011474609375
▁ 0.0010709762573242188
2 0.00014197826385498047
0 6.0677528381347656e-05
1 0.00034737586975097656
7 0.0039520263671875
). 0.0164794921875
▁It 1.8828125
▁can 3.20703125
▁be 0.6220703125
▁fairly 8.1015625
▁explained 1.380859375
▁by 0.223388671875
▁the 0.251220703125
▁weak 7.87109375
▁focus 6.7578125
▁of 0.76806640625
▁respond 5.42578125
ents 0.1331787109375
▁who 3.69140625
▁have 3.779296875
▁overcome 8.71875
▁severe 2.021484375
▁pain 0.521484375
▁sens 8.2890625
ations 0.2418212890625
▁and 0.83984375
▁de 4.64453125
press 0.9814453125
ive 0.05841064453125
▁episodes 2.091796875
. 0.51904296875
▁It 2.697265625
▁is 0.5966796875
▁not 2.494140625
▁clear 3.76953125
▁how 1.9521484375
▁to 3.8828125
▁use 5.859375
▁these 3.046875
▁statistics 3.736328125
, 2.728515625
▁as 0.72802734375
▁they 1.9423828125
▁still 5.28515625
▁may 4.58203125
▁be 1.40234375
▁relevant 4.4375
▁for 1.71875
▁the 1.427734375
▁overall 4.375
▁analysis 2.048828125
. 0.6103515625
<0x0A> 1.3251953125
Am 5.9609375
ong 0.00917816162109375
▁all 2.56640625
▁participants 1.470703125
▁in 3.615234375
▁the 0.1507568359375
▁study 0.5390625
, 0.046966552734375
▁ 0.71484375
4 1.892578125
2 2.318359375
. 1.4970703125
2 2.265625
% 0.047607421875
▁suffered 4.1640625
▁from 0.048675537109375
▁de 1.5859375
pression 0.35009765625
, 1.0634765625
▁and 1.3857421875
▁ 0.12213134765625
3 1.40625
7 2.3515625
% 2.451171875
▁experienced 2.046875
▁excess 7.08984375
ive 0.02960205078125
▁anx 0.1917724609375
iety 0.001834869384765625
. 0.65283203125
▁The 1.4990234375
▁pl 10.75
ur 0.66015625
ality 0.0006117820739746094
▁of 0.1307373046875
▁de 2.76953125
press 1.1708984375
ive 0.02923583984375
▁dis 2.388671875
orders 0.07537841796875
▁among 2.865234375
▁patients 1.1435546875
▁in 2.990234375
▁the 0.2548828125
▁op 0.58251953125
i 0.4580078125
ates 0.0012302398681640625
, 9.1953125
▁medical 3.611328125
▁mar 0.024993896484375
iju 0.0007128715515136719
ana 1.2516975402832031e-05
, 0.1690673828125
▁and 0.09173583984375
▁mixed 1.560546875
▁OP 11.3203125
MM 4.046875
▁groups 0.6435546875
▁number 9.46875
ed 0.0379638671875
▁ 0.1746826171875
5 1.986328125
7 2.6796875
. 0.5771484375
1 2.470703125
%, 0.2017822265625
▁ 0.0033206939697265625
2 2.40234375
2 2.62890625
. 0.126708984375
3 2.263671875
%, 0.04595947265625
▁and 0.058135986328125
▁ 0.0018405914306640625
5 2.037109375
1 2.154296875
. 0.181640625
4 1.767578125
%, 0.1810302734375
▁respectively 0.0242919921875
. 0.61865234375
▁The 1.29296875
▁pl 3.828125
ur 0.0119781494140625
ality 6.175041198730469e-05
▁of 0.0294342041015625
▁anx 0.426513671875
iety 0.016021728515625
▁contained 10.7265625
▁ 0.21875
4 1.1689453125
8 2.404296875
. 0.191650390625
4 2.185546875
% 2.037109375
▁among 2.46875
▁OP 4.85546875
▁patients 6.29296875
, 0.2802734375
▁ 0.08538818359375
2 1.0087890625
1 2.482421875
. 0.1226806640625
5 2.109375
% 0.0291900634765625
▁among 0.482177734375
▁MM 0.09820556640625
▁patients 0.407958984375
, 0.0174407958984375
▁and 0.0189361572265625
▁ 0.0266265869140625
3 1.306640625
8 1.978515625
. 0.135009765625
7 2.283203125
% 0.01177215576171875
▁among 0.1943359375
▁OP 2.138671875
MM 0.1448974609375
▁participants 3.4921875
. 0.50146484375
▁Pat 5.59765625
ients 0.01727294921875
▁who 1.7568359375
▁took 2.58203125
▁strong 10.0546875
▁op 0.90869140625
i 0.921875
ates 0.003894805908203125
▁were 1.177734375
▁t 10.15625
ended 1.0634765625
▁to 0.00798797607421875
▁place 10.2578125
▁their 2.486328125
▁pain 3.6640625
▁on 1.8486328125
▁a 0.81005859375
▁scale 2.40625
▁of 0.336181640625
▁ 0.2060546875
9 2.322265625
▁to 2.349609375
▁ 0.0107269287109375
1 0.0082855224609375
0 0.05218505859375
▁( 2.21875
Fe 0.67578125
ing 0.002124786376953125
old 0.0003104209899902344
▁et 0.00676727294921875
▁al 0.0006518363952636719
., 0.00670623779296875
▁ 0.0007615089416503906
2 0.0001659393310546875
0 3.039836883544922e-05
1 0.0006203651428222656
7 0.0025463104248046875
). 0.0166778564453125
▁They 3.73828125
▁were 1.6396484375
▁also 1.0791015625
▁an 9.5703125
gu 4.6015625
ished 0.07586669921875
▁em 6.3828125
otion 0.0012350082397460938
ally 0.0005593299865722656
▁and 0.9833984375
▁react 7.1171875
ed 0.0215606689453125
▁rad 8.75
ically 0.001712799072265625
▁neg 4.96875
atively 0.0012416839599609375
▁to 0.17919921875
▁almost 5.34375
▁all 1.568359375
▁survey 3.619140625
▁questions 0.2254638671875
. 0.31298828125
▁Pat 3.72265625
ients 0.004314422607421875
▁who 1.1669921875
▁took 1.7763671875
▁only 4.46484375
▁MM 0.36669921875
▁or 2.57421875
▁mixed 2.58984375
▁medic 1.287109375
ations 0.2044677734375
▁course 13.7265625
▁had 2.55859375
▁a 1.37109375
▁significantly 2.970703125
▁more 3.11328125
▁stable 2.798828125
▁emot 0.880859375
ional 0.0010175704956054688
▁state 0.548828125
▁and 1.2548828125
▁cop 6.80078125
ed 0.026336669921875
▁with 0.317138671875
▁pain 0.8818359375
▁more 1.884765625
▁manage 6.69140625
able 1.3955078125
. 0.331298828125
<0x0A> 0.30029296875
The 0.908203125
▁question 6.17578125
na 1.5732421875
ires 6.699562072753906e-05
▁used 1.759765625
▁different 8.703125
▁variable 8.734375
▁measures 0.4677734375
▁to 1.6875
▁collect 2.734375
▁information 1.6787109375
. 1.2353515625
▁For 2.115234375
▁example 0.196533203125
, 0.0010242462158203125
▁it 3.619140625
▁included 2.30078125
▁compreh 8.4921875
ensive 0.07196044921875
▁so 6.05078125
cio 0.00257110595703125
- 0.2110595703125
dem 0.10137939453125
ographic 0.0733642578125
▁data 0.93505859375
: 4.88671875
▁gender 1.9453125
, 0.05029296875
▁age 0.26953125
, 0.034271240234375
▁country 4.078125
, 2.392578125
▁type 4.3984375
▁of 0.0523681640625
▁residence 3.70703125
▁( 2.63671875
urban 0.6650390625
/ 1.544921875
r 0.1663818359375
ural 0.001338958740234375
), 0.182373046875
▁years 6.12890625
▁of 0.1756591796875
▁education 0.74072265625
, 0.0943603515625
▁and 1.4306640625
▁employ 2.591796875
ment 0.0022182464599609375
▁status 0.79736328125
. 0.258544921875
▁Pat 4.1015625
ients 0.0748291015625
▁were 1.091796875
▁also 0.7255859375
▁asked 0.54931640625
▁about 0.97119140625
▁their 0.8193359375
▁medical 2.701171875
▁history 0.5126953125
▁over 8.5
▁the 0.07275390625
▁years 4.71484375
▁and 1.6533203125
▁the 1.466796875
▁current 3.134765625
▁presence 4.921875
▁of 0.0753173828125
▁any 2.47265625
▁severe 3.640625
▁dise 1.7353515625
ases 8.976459503173828e-05
▁such 4.625
▁as 0.0010900497436523438
▁heart 2.607421875
▁failure 1.751953125
, 0.288330078125
▁di 1.61328125
ab 0.0008373260498046875
etes 0.0027256011962890625
, 0.072998046875
▁ar 4.12890625
th 0.181640625
rit 0.0362548828125
is 0.004791259765625
, 0.02496337890625
▁and 1.2197265625
▁so 0.8671875
▁on 0.064697265625
. 0.07427978515625
▁The 1.650390625
▁third 6.9296875
▁measure 3.734375
▁of 2.791015625
▁the 0.81103515625
▁question 1.3369140625
naire 0.2198486328125
▁was 1.13671875
▁indicated 10.75
▁by 1.2294921875
▁information 7.23828125
▁on 2.103515625
▁any 5.76953125
▁twelve 14.1484375
- 0.26806640625
month 0.18798828125
▁and 4.94140625
▁lifetime 0.77099609375
▁drug 3.43359375
▁and 1.7294921875
▁alco 0.10540771484375
hol 7.855892181396484e-05
▁consumption 4.03125
. 0.479736328125
▁In 3.611328125
▁addition 0.96240234375
, 0.201904296875
▁the 1.091796875
▁record 10.2421875
▁included 1.4345703125
▁a 2.677734375
▁pain 4.453125
▁measurement 4.73046875
▁scale 0.513671875
▁from 2.736328125
▁ 0.167724609375
0 0.299072265625
▁to 0.135986328125
▁ 0.0038433074951171875
1 0.0191192626953125
0 0.020355224609375
▁to 3.828125
▁evaluate 1.4853515625
▁dis 6.33203125
com 0.0870361328125
fort 0.0012903213500976562
▁feelings 7.33984375
▁during 4.1953125
▁the 0.293212890625
▁last 0.98486328125
▁month 1.7392578125
. 0.330078125
